These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 15790528)

  • 1. Stem cells may reshape the prospect of Parkinson's disease therapy.
    Sonntag KC; Simantov R; Isacson O
    Brain Res Mol Brain Res; 2005 Mar; 134(1):34-51. PubMed ID: 15790528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering a dopaminergic phenotype in stem/precursor cells: role of Nurr1, glia-derived signals, and Wnts.
    Arenas E
    Ann N Y Acad Sci; 2005 May; 1049():51-66. PubMed ID: 15965107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.
    Isacson O; Bjorklund LM; Schumacher JM
    Ann Neurol; 2003; 53 Suppl 3():S135-46; discussion S146-8. PubMed ID: 12666105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell therapy for Parkinson's disease: problems and prospects.
    Björklund A
    Novartis Found Symp; 2005; 265():174-86; discussion 187, 204-211. PubMed ID: 16050257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cripto as a target for improving embryonic stem cell-based therapy in Parkinson's disease.
    Parish CL; Parisi S; Persico MG; Arenas E; Minchiotti G
    Stem Cells; 2005 Apr; 23(4):471-6. PubMed ID: 15790767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.
    Kim JH; Auerbach JM; Rodríguez-Gómez JA; Velasco I; Gavin D; Lumelsky N; Lee SH; Nguyen J; Sánchez-Pernaute R; Bankiewicz K; McKay R
    Nature; 2002 Jul; 418(6893):50-6. PubMed ID: 12077607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current state of stem cell research for the treatment of Parkinson's disease.
    Gerlach M; Braak H; Hartmann A; Jost WH; Odin P; Priller J; Schwarz J
    J Neurol; 2002 Oct; 249 Suppl 3():III/33-5. PubMed ID: 12522570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of graftable dopaminergic neuron progenitors from mouse ES cells by a combination of coculture and neurosphere methods.
    Morizane A; Takahashi J; Shinoyama M; Ideguchi M; Takagi Y; Fukuda H; Koyanagi M; Sasai Y; Hashimoto N
    J Neurosci Res; 2006 May; 83(6):1015-27. PubMed ID: 16493682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease.
    Muramatsu S; Okuno T; Suzuki Y; Nakayama T; Kakiuchi T; Takino N; Iida A; Ono F; Terao K; Inoue N; Nakano I; Kondo Y; Tsukada H
    Synapse; 2009 Jul; 63(7):541-8. PubMed ID: 19253400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence-activated cell sorting-based purification of embryonic stem cell-derived neural precursors averts tumor formation after transplantation.
    Fukuda H; Takahashi J; Watanabe K; Hayashi H; Morizane A; Koyanagi M; Sasai Y; Hashimoto N
    Stem Cells; 2006 Mar; 24(3):763-71. PubMed ID: 16223855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.
    Taylor H; Minger SL
    Curr Opin Biotechnol; 2005 Oct; 16(5):487-92. PubMed ID: 16143504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cell therapy in Parkinson's disease].
    Shingo T
    Rinsho Shinkeigaku; 2004 Nov; 44(11):951-3. PubMed ID: 15651341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease.
    Lindvall O; Kokaia Z
    Trends Pharmacol Sci; 2009 May; 30(5):260-7. PubMed ID: 19362379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restorative approaches in Parkinson's Disease: which cell type wins the race?
    Meyer AK; Maisel M; Hermann A; Stirl K; Storch A
    J Neurol Sci; 2010 Feb; 289(1-2):93-103. PubMed ID: 19733367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell-based therapy for Parkinson's disease.
    Correia AS; Anisimov SV; Li JY; Brundin P
    Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation of functional dopamine neurons from embryonic stem cells.
    Kim DS; Kim JY; Kang M; Cho MS; Kim DW
    Cell Transplant; 2007; 16(2):117-23. PubMed ID: 17474293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologically active microcarriers releasing glial cell line - derived neurotrophic factor: Survival and differentiation of embryonic dopaminergic neurons after grafting in hemiparkinsonian rats.
    Tatard VM; Sindji L; Branton JG; Aubert-Pouëssel A; Colleau J; Benoit JP; Montero-Menei CN
    Biomaterials; 2007 Apr; 28(11):1978-88. PubMed ID: 17240442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and early functional integration of dopaminergic progenitor cells following transplantation in a rat model of Parkinson's disease.
    Hahn M; Timmer M; Nikkhah G
    J Neurosci Res; 2009 Jul; 87(9):2006-19. PubMed ID: 19235889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem-cell-based strategies for the treatment of Parkinson's disease.
    Parish CL; Arenas E
    Neurodegener Dis; 2007; 4(4):339-47. PubMed ID: 17627139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of functional dopamine neurons from neural precursor cells isolated from the subventricular zone and white matter of the adult rat brain using Nurr1 overexpression.
    Shim JW; Park CH; Bae YC; Bae JY; Chung S; Chang MY; Koh HC; Lee HS; Hwang SJ; Lee KH; Lee YS; Choi CY; Lee SH
    Stem Cells; 2007 May; 25(5):1252-62. PubMed ID: 17234994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.